
|Articles|March 20, 2008
DigiFab production increased to combat temporary antibody shortage
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Advertisement
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































